Podder, Vivek
Ranjan, Tulika
Gowda, Maya
Camacho, Alejandra M.
Ahluwalia, Manmeet S.
Article History
Accepted: 19 October 2024
First Online: 3 December 2024
Declarations
:
: Conflict of interest: VP, TR, MG, and AMC report no financial or non-financial conflicts of interest. MSA has received grants from Seagen and holds consulting roles with several companies, including Bayer, Kiyatec, Insightec, GSK, Xoft, Nuvation, SDP Oncology, Apollomics, Prelude, Janssen, Voyager Therapeutics, Viewray, Caris Lifesciences, Pyramid Biosciences, Varian Medical Systems, Cairn Therapeutics, Anheart Therapeutics, Theraguix, Menarini Ricerche, Sumitomo Pharma Oncology, Autem Therapeutics, GT Medical Technologies, Allovir, and Equillium Bio. He is on the Data Safety Monitoring Committee for VBI Vaccines and serves on the Scientific Advisory Board for Modifi Biosciences and Bugworks. Additionally, MSA is a shareholder in Mimivax, Cytodyn, MedInnovate Advisors LLC, and Trisalus Lifesciences.
: This article does not contain any studies with human or animal subjects performed by any of the authors.